It wasn't a rhetorical question. I could imagine an entity like the Gates Foundation proving seed funding to bootstrap a non-profit pharmaceutical company. That company could fund R&D through sales of its newly developed medicines. No shareholders. No stock buybacks. But somehow this doesn't seem to happen, at least not on a scale that reduces medical costs for consumers.